Literature DB >> 12358267

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

Robert P Myers1, Vlad Ratziu, Françoise Imbert-Bismut, Frédéric Charlotte, Thierry Poynard.   

Abstract

OBJECTIVES: Liver fibrosis in chronic hepatitis C is related to sex, age at infection, duration of infection, and alcohol consumption. Several noninvasive biochemical markers are highly predictive for the discrimination of significant fibrosis. The aims of this study were: 1) to compare an index of five biochemical markers with historical features; and 2) to determine the utility of combining these features with the five-marker index for the prediction of significant fibrosis.
METHODS: Untreated patients with chronic hepatitis C and a known duration of infection had a liver biopsy and serum tested for markers of fibrosis. The discriminative values of the markers and an index of historical features for the diagnosis of clinically significant fibrosis (F2-F4 by the Metavir system) were compared using areas under receiver operating characteristic (ROC) curves. A modified index was constructed combining the five-marker index and historical features.
RESULTS: A total of 211 patients were included. Of these, 52% were male, and 19% consumed > or = 50 g of alcohol daily. The median age at infection was 28 +/- 13 yr and the median duration of infection was 17 +/- 8 yr (range 1-48 yr). By multivariate logistic regression analysis, sex (p = 0.003), age at biopsy (p = 0.004), and alcohol consumption (p = 0.042) were independently predictive of F2-F4 fibrosis. For the discrimination of F2-F4 fibrosis, the areas under the ROC curves were 0.796 +/- 0.033 for the five-marker index versus 0.709 +/- 0.037 for the historical index (p = 0.079). For diagnosis of advanced fibrosis (F3 and F4), the areas under the curves were 0.920 +/- 0.032 and 0.762 +/- 0.049 (p = 0.007), respectively. The discriminative value of the combined biochemical and historical index was not statistically significantly different from that of the five-marker index alone (p = ns).
CONCLUSIONS: A simple index including age, sex, and five biochemical markers accurately predicts significant hepatitis C-related fibrosis. This index is more accurate than an index of historical features, the addition of which to the existing index was not helpful.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358267     DOI: 10.1111/j.1572-0241.2002.05997.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  22 in total

Review 1.  Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C.

Authors:  Laurent Castera; Jean-Michel Pawlotsky
Journal:  MedGenMed       Date:  2005-11-09

2.  Is it better to use two elastographic methods for liver fibrosis assessment?

Authors:  Ioan Sporea; Roxana Şirli; Alina Popescu; Simona Bota; Radu Badea; Monica Lupşor; Mircea Focşa; Mirela Dănilă
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

3.  Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.

Authors:  Lindsay C Burrage; Simran Madan; Xiaohui Li; Saima Ali; Mahmoud Mohammad; Bridget M Stroup; Ming-Ming Jiang; Racel Cela; Terry Bertin; Zixue Jin; Jian Dai; Danielle Guffey; Milton Finegold; Sandesh Nagamani; Charles G Minard; Juan Marini; Prakash Masand; Deborah Schady; Benjamin L Shneider; Daniel H Leung; Deeksha Bali; Brendan Lee
Journal:  JCI Insight       Date:  2020-02-27

4.  Establishment and validation of a simple noninvasive model to predict significant liver fibrosis in patients with chronic hepatitis B.

Authors:  Sheng-di Wu; Yan-Jun Ni; Li-Li Liu; Hai Li; Lun-Gen Lu; Ji-Yao Wang
Journal:  Hepatol Int       Date:  2011-12-10       Impact factor: 6.047

5.  Low plasma apolipoprotein A-I level is not a reliable marker of fibrosis in children with chronic hepatitis B.

Authors:  Mukadder-Ayse Selimoglu; Rasit-Vural Yagcl; Gül Yüce
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

6.  Relationship between clinical and pathologic findings in patients with chronic liver diseases.

Authors:  Lun-Gen Lu; Min-De Zeng; Yi-Min Mao; Ji-Qiang Li; De-Kai Qiu; Jing-Yuan Fang; Ai-Ping Cao; Mo-Bin Wan; Cheng-Zhong Li; Jun Ye; Xiong Cai; Cheng-Wei Chen; Ji-Yao Wang; Shan-Ming Wu; Jin-Shui Zhu; Xia-Qiu Zhou
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

7.  Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI.

Authors:  Ai-Sheng Ho; Chun-Chia Cheng; Shui-Cheng Lee; Meng-Lun Liu; Jing-Ying Lee; Wen-Ming Wang; Chia-Chi Wang
Journal:  J Biomed Sci       Date:  2010-07-15       Impact factor: 8.410

Review 8.  Why, who and how should perform liver biopsy in chronic liver diseases.

Authors:  Ioan Sporea; Alina Popescu; Roxana Sirli
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

9.  Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters.

Authors:  Lun-Gen Lu; Min-De Zeng; Mo-Bin Wan; Cheng-Zhong Li; Yi-Min Mao; Ji-Qiang Li; De-Kai Qiu; Ai-Ping Cao; Jun Ye; Xiong Cai; Cheng-Wei Chen; Ji-Yao Wang; Shan-Ming Wu; Jin-Shui Zhu; Xia-Qiu Zhou
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

10.  Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study.

Authors:  Sheng-Di Wu; Ji-Yao Wang; Lei Li
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.